Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer

Abstract Background Lung cancer patients face a high risk of thromboembolism (TE), which is considered to be a poor prognostic factor. However, the impact of symptomatic cerebral infarction (CI) and pulmonary embolism (PE) on the prognosis of advanced non‐small cell lung cancer (NSCLC) patients is n...

Full description

Bibliographic Details
Main Authors: Ryota Nakamura, Tadaaki Yamada, Satomi Tanaka, Aosa Sasada, Shinsuke Shiotsu, Nozomi Tani, Takayuki Takeda, Yusuke Chihara, Soichi Hirai, Yoshizumi Takemura, Akihiro Yoshimura, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Young Hak Kim, Koichi Takayama
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5647
_version_ 1827951732547649536
author Ryota Nakamura
Tadaaki Yamada
Satomi Tanaka
Aosa Sasada
Shinsuke Shiotsu
Nozomi Tani
Takayuki Takeda
Yusuke Chihara
Soichi Hirai
Yoshizumi Takemura
Akihiro Yoshimura
Kenji Morimoto
Masahiro Iwasaku
Shinsaku Tokuda
Young Hak Kim
Koichi Takayama
author_facet Ryota Nakamura
Tadaaki Yamada
Satomi Tanaka
Aosa Sasada
Shinsuke Shiotsu
Nozomi Tani
Takayuki Takeda
Yusuke Chihara
Soichi Hirai
Yoshizumi Takemura
Akihiro Yoshimura
Kenji Morimoto
Masahiro Iwasaku
Shinsaku Tokuda
Young Hak Kim
Koichi Takayama
author_sort Ryota Nakamura
collection DOAJ
description Abstract Background Lung cancer patients face a high risk of thromboembolism (TE), which is considered to be a poor prognostic factor. However, the impact of symptomatic cerebral infarction (CI) and pulmonary embolism (PE) on the prognosis of advanced non‐small cell lung cancer (NSCLC) patients is not fully understood. Methods We retrospectively identified 46 patients with advanced NSCLC who developed symptomatic CI or PE at five hospitals in Japan between January 2010 and December 2019. Prognosis and biomarker levels after incident CI and PE were investigated. Results Of the 46 patients, 36 developed symptomatic CI, and 10 developed symptomatic PE. The median follow‐up duration after incident CI and PE was 18.2 months. Although the proportion of Common Terminology Criteria for Adverse Events grade 4 tended to be higher in patients with PE than in those with CI (30% vs. 11%, p = 0.16), the overall survival (OS) after incident TE tended to be worse in patients with CI than in those with PE (median 2.3 months vs. 9.1 months, log‐rank test p = 0.17). Multivariate analysis showed that OS after CI was worse in patients with high D‐dimer (DD) levels than in those with low DD levels at the time of incident CI (median 1.3 months vs. 8.3 months, log‐rank p < 0.001). Conclusions This retrospective study demonstrated that the prognosis of patients tended to be poorer after CI than after PE. The DD levels at the time of incident CI might be a promising predictor of clinical outcomes in advanced NSCLC patients who develop CI.
first_indexed 2024-04-09T13:45:56Z
format Article
id doaj.art-69b2b1be97d84bcea46fd2c77252efe8
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-09T13:45:56Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-69b2b1be97d84bcea46fd2c77252efe82023-05-09T04:04:18ZengWileyCancer Medicine2045-76342023-04-011289097910510.1002/cam4.5647Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancerRyota Nakamura0Tadaaki Yamada1Satomi Tanaka2Aosa Sasada3Shinsuke Shiotsu4Nozomi Tani5Takayuki Takeda6Yusuke Chihara7Soichi Hirai8Yoshizumi Takemura9Akihiro Yoshimura10Kenji Morimoto11Masahiro Iwasaku12Shinsaku Tokuda13Young Hak Kim14Koichi Takayama15Department of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Respiratory Medicine Japanese Red Cross Kyoto Daiichi Hospital Kyoto JapanDepartment of Respiratory Medicine Japanese Red Cross Kyoto Daiichi Hospital Kyoto JapanDepartment of Pulmonary Medicine Japan Community Health care Organization Kyoto Kuramaguchi Medical Center Kyoto JapanDepartment of Respiratory Medicine Japanese Red Cross Kyoto Daini Hospital Kyoto JapanDepartment of Respiratory Medicine Uji‐Tokushukai Medical Center Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine Otsu City Hospital Shiga JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanAbstract Background Lung cancer patients face a high risk of thromboembolism (TE), which is considered to be a poor prognostic factor. However, the impact of symptomatic cerebral infarction (CI) and pulmonary embolism (PE) on the prognosis of advanced non‐small cell lung cancer (NSCLC) patients is not fully understood. Methods We retrospectively identified 46 patients with advanced NSCLC who developed symptomatic CI or PE at five hospitals in Japan between January 2010 and December 2019. Prognosis and biomarker levels after incident CI and PE were investigated. Results Of the 46 patients, 36 developed symptomatic CI, and 10 developed symptomatic PE. The median follow‐up duration after incident CI and PE was 18.2 months. Although the proportion of Common Terminology Criteria for Adverse Events grade 4 tended to be higher in patients with PE than in those with CI (30% vs. 11%, p = 0.16), the overall survival (OS) after incident TE tended to be worse in patients with CI than in those with PE (median 2.3 months vs. 9.1 months, log‐rank test p = 0.17). Multivariate analysis showed that OS after CI was worse in patients with high D‐dimer (DD) levels than in those with low DD levels at the time of incident CI (median 1.3 months vs. 8.3 months, log‐rank p < 0.001). Conclusions This retrospective study demonstrated that the prognosis of patients tended to be poorer after CI than after PE. The DD levels at the time of incident CI might be a promising predictor of clinical outcomes in advanced NSCLC patients who develop CI.https://doi.org/10.1002/cam4.5647cerebral infarctionischemic strokenon‐small cell lung cancerpulmonary embolismthromboembolism
spellingShingle Ryota Nakamura
Tadaaki Yamada
Satomi Tanaka
Aosa Sasada
Shinsuke Shiotsu
Nozomi Tani
Takayuki Takeda
Yusuke Chihara
Soichi Hirai
Yoshizumi Takemura
Akihiro Yoshimura
Kenji Morimoto
Masahiro Iwasaku
Shinsaku Tokuda
Young Hak Kim
Koichi Takayama
Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
Cancer Medicine
cerebral infarction
ischemic stroke
non‐small cell lung cancer
pulmonary embolism
thromboembolism
title Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
title_full Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
title_fullStr Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
title_full_unstemmed Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
title_short Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
title_sort comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non small cell lung cancer
topic cerebral infarction
ischemic stroke
non‐small cell lung cancer
pulmonary embolism
thromboembolism
url https://doi.org/10.1002/cam4.5647
work_keys_str_mv AT ryotanakamura comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT tadaakiyamada comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT satomitanaka comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT aosasasada comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT shinsukeshiotsu comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT nozomitani comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT takayukitakeda comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT yusukechihara comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT soichihirai comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT yoshizumitakemura comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT akihiroyoshimura comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT kenjimorimoto comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT masahiroiwasaku comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT shinsakutokuda comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT younghakkim comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer
AT koichitakayama comparisonoftheprognosisofsymptomaticcerebralinfarctionandpulmonaryembolisminpatientswithadvancednonsmallcelllungcancer